DescriptionThe securities of Melodiol Global Health Limited (‘ME1’) will be placed in trading halt at the request of ME1, pending it releasing an announcement. Unless ASX decides otherwise, the securities will remain in trading halt until the earlier of the commencement of normal trading on Monday, 13 November 2023 or when the announcement is released to the market. Issued byScarlette de Lavaine Adviser, Listings ComplianceClick here for the full ASX ReleaseThis article includes content from Melodiol Global Health, licensed for the purpose of publishing on Investing News Australia. This article does not constitute financial product advice. It is your responsibility to perform proper due diligence before acting upon any information provided here. Please refer to our full disclaimer here.
Source link
Curtin University, Draslovka partner to advance glycine leaching technology
Reading Time: < 1 minute“The non-toxic amino acid has the potential to replace hazardous chemicals like cyanide in mineral
November 23, 2024
